Trials / Completed
CompletedNCT00652600
Bioavailability Study of Propranolol Under Fed Conditions
Comparative, Randomized, Single-Dose, 2 Way Cross Over Bioavailability Study of Par Propranolol 160 mg With That of Inderal-LA Propranolol 160 mg in Healthy Subjects Under Fed Conditions.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Par Pharmaceutical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To compare the single-dose bioavailability of Propranolol 160 Mg ER Capsules with Inderal-La
Detailed description
To compare the single -dose bioavailability of Par Propranolol 160 Mg ER capsules with Wyeth Pharmaceuticals, Inderal-LA, Propranolol under fed conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propranolol | ER Capsules, 160 mg, single-dose |
| DRUG | Inderal-LA | ER Capsules, 160 mg, single-dose |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2008-04-04
- Last updated
- 2017-09-26
Source: ClinicalTrials.gov record NCT00652600. Inclusion in this directory is not an endorsement.